Effective use of the human and mouse genomes requires reliable identification of genes and their products. Although multiple public resources provide annotation, different methods are used that can result in similar but not identical representation of genes, transcripts, and proteins. The collaborative consensus coding sequence (CCDS) project tracks identical protein annotations on the reference mouse and human genomes with a stable identifier (CCDS ID), and ensures that they are consistently represented on the NCBI, Ensembl, and UCSC Genome Browsers. Importantly, the project coordinates on manually reviewing inconsistent protein annotations between sites, as well as annotations for which new evidence suggests a revision is needed, to progressively converge on a complete protein-coding set for the human and mouse reference genomes, while maintaining a high standard of reliability and biological accuracy. To date, the project has identified 20,159 human and 17,707 mouse consensus coding regions from 17,052 human and 16,893 mouse genes. Three evaluation methods indicate that the entries in the CCDS set are highly likely to represent real proteins, more so than annotations from contributing groups not included in CCDS. The CCDS database thus centralizes the function of identifying well-supported, identically-annotated, protein-coding regions.
Effective use of the human and mouse genomes requires reliable identification of genes and their products. Although multiple public resources provide annotation, different methods are used that can result in similar but not identical representation of genes, transcripts, and proteins. The collaborative consensus coding sequence (CCDS) project tracks identical protein annotations on the reference mouse and human genomes with a stable identifier (CCDS ID), and ensures that they are consistently represented on the NCBI, Ensembl, and UCSC Genome Browsers. Importantly, the project coordinates on manually reviewing inconsistent protein annotations between sites, as well as annotations for which new evidence suggests a revision is needed, to progressively converge on a complete protein-coding set for the human and mouse reference genomes, while maintaining a high standard of reliability and biological accuracy. To date, the project has identified 20,159 human and 17,707 mouse consensus coding regions from 17,052 human and 16,893 mouse genes. Three evaluation methods indicate that the entries in the CCDS set are highly likely to represent real proteins, more so than annotations from contributing groups not included in CCDS. The CCDS database thus centralizes the function of identifying well-supported, identically-annotated, protein-coding regions.
[Supplemental material is available online at www.genome.org. Data sets and documentation are available in the CCDS database at http://www.ncbi.nlm.nih.gov/CCDS.]
One key goal of genome projects is to identify and accurately annotate all protein-coding genes. The resulting annotations add functional context to the sequence data and make it easier to traverse to other rich sources of gene and protein information. Accurately annotating known genes, identifying novel genes, and tracking annotations over time are complex processes that are best achieved through a combination of large-scale computational analyses and expert curation. These methods must (1) process repetitive sequences in multiple categories including retrotransposons, segmental duplications, and paralogs; (2) process variation including copy number variation (CNV) (Feuk et al. 2006 ) and microsatellites; (3) distinguish functional genes and alleles from pseudogenes; (4) define alternate splice products; and (5) avoid erroneous interpretation based on experimental error.
Genome annotation information is available from many sources including publications on the sequencing and annotation of genes for whole genomes, individual chromosomes, and wholegenome annotation computed by multiple bioinformatics groups. Ensembl and the National Center for Biotechnology Information (NCBI) independently developed computational processes to annotate vertebrate genomes (Kitts 2002; Potter et al. 2004) . Both pipelines predict genes, transcripts, and proteins based on interpretations of gene prediction programs, transcript alignments, and protein alignments. In addition, manual annotation is provided by the Havana group at the Wellcome Trust Sanger Institute (WTSI) and the Reference Sequence (RefSeq) group at the National Center for Biotechnology Information (NCBI).
The abundance of different data sources has been problematic for the scientific community since annotated models may change over time as more experimental data accumulate, or may differ among annotation groups owing to differences in methodology or data used. Differences in presentation can also compound the problem. Assigning a unique, tracked accession (CCDS ID) to identical coding region annotations removes some of the uncertainty by explicitly noting where consensus protein annotation has been identified, independent of the website being used. ''Consensus'' is defined as protein-coding regions that agree at the start codon, stop codon, and splice junctions, and for which the prediction meets quality assurance benchmarks. Thus, a distinguishing feature of the collaborative consensus coding sequence (CCDS) project compared to other protein databases is the integrated tracking of protein sequences in the context of the genome sequence. The current CCDS data sets for human and mouse can be accessed from several public resources including the members of the CCDS collaboration, namely: (1) the Ensembl Genome Browser, which is a joint project between the European Bioinformatics Institute (EBI) and WTSI (Birney et al. 2004) ; (2) the NCBI Map Viewer (Dombrowski and Maglott 2002) ; (3) the University of California Santa Cruz (UCSC) Genome Browser Zweig et al. 2008) ; and (4) the WTSI Vertebrate Genome Annotation (Vega) Genome Browser (Ashurst et al. 2005) . The CCDS collaborators provide access to the same reference genomic sequence and CCDS data set.
The CCDS set is built by consensus; each member of the collaboration contributes annotation, quality assessments, and curation. The collaboration pragmatically defines the initial focus on coding region annotations, rather than the annotated transcripts including untranslated regions (UTRs), because it is critical to identify encoded proteins and because there is more variation in UTR annotation. Protein-coding region annotations that do not satisfy the criteria for assigning a CCDS ID are evaluated between releases so that the annotation continues to improve. The key goal of the CCDS project is to provide a complete set of high-quality annotations of protein-coding genes on the human and mouse genomes.
Results
We have developed the process flow, quality assurance tests, curation infrastructure, and web resources to support identification, tracking, and reporting of identical protein annotations. Table 1 summarizes the growth of the CCDS database since its first release in 2005.
Following a coordinated annotation update of the reference genome annotation, results are compared to identify identical protein-coding regions. Each coding sequence (CDS) annotation must then pass quality assessment tests before being assigned a CCDS ID and version number (see Methods; Supplemental Fig.  4 ). The CCDS ID is stable, and every effort is made to ensure that all protein-coding regions with existing CCDS IDs are consistently annotated with each whole-genome annotation update. The protein sequence defined for the CCDS ID is the predicted translation of the coding sequence that is annotated on the genomic reference chromosome. Thus it is identical to the sequence reported by Ensembl, UCSC, and Vega. The sequence may differ at individual amino acids from associated RefSeq records (Pruitt et al. 2009 ) because the latter are often based on translations of independently generated mRNA sequences that may be selected to represent a different allele.
Quality assessment
We assessed the content and quality of the current public CCDS collection using three metrics: (1) evaluation of NCBI HomoloGene clusters to determine the number of homologous pairs of human and mouse CCDS proteins, (2) comparison of CCDS proteins to the curated UniProtKb/SWISS-PROT protein data set (hereto after referred to as ''SWISS-PROT''), and (3) evaluation of genome conservation. HomoloGene (http://www.ncbi.nlm.nih. gov/sites/entrez?db=homologene) (Wheeler et al. 2008 ) reports groups of related proteins annotated on reference chromosomes for select species and includes a consideration of local conserved synteny that is limited to an assessment of flanking genes. HomoloGene is a gene-oriented resource as calculation is based on b If unexpected losses, indicated in the ''Withdrawn, Other'' column, are found in a later build, the CCDS ID is reinstated with a ''public'' status. Reinstatement requires that the CDS structure be identical to the version that was previously lost, or, if the CDS structure has changed and is found as identical in both input data sets, then the CCDS version number is incremented. For example, see CCDS2672. c Unexpected loss of consistent CDS annotation includes changed or removed annotation that is not tracked by the CCDS database as curation-based change. The large accidental loss in human build 36.2 resulted in improved tracking of annotation input data by both the NCBI and Ensembl annotation pipelines. Robust CCDS tracking continues to be a goal of annotation pipelines.
a single longest protein per annotated locus and excludes additional annotated proteins that may be available from consideration (Sayers et al. 2009 ). There are 16,590 HomoloGene clusters that include proteins from both human and mouse; 15,963 of these have at least one protein with a CCDS ID, and 13,329 clusters include proteins with CCDS IDs from both human and mouse. When the latter subset is evaluated for length of protein product, 68% are within 30 amino acids and 25% are identical. Note that because there are fewer CCDS proteins in mouse, assessing the quality of the annotation by counts of HomoloGene clusters with both human and mouse CCDS members may underrepresent the conservation of annotations. Of the human and mouse protein-coding genes with an associated CCDS ID, 96.5% of the human genes and 95.4% of the mouse genes (16,461 and 16,114, respectively) are clustered by HomoloGene with at least one homolog from any other species (see Fig. 1 ).
A second approach to assess the CCDS data set is to compare the derived protein sequences to another curated protein data set, namely, the SWISS-PROT records available for human and mouse. Of the 35,505 human and mouse SWISS-PROT records available at the time of this analysis (release 55.5), 81% match a CCDS protein at or above 95% identity, of which 66% are identical. Similar numbers are found for the human and mouse CCDS data sets (see Fig. 2 ). A complete match between the CCDS data set and that of SWISS-PROT is not expected because these two resources are generated using very different data models; SWISS-PROT is a protein-oriented resource that doesn't require consistency with the reference genome sequence, whereas CCDS proteins do have that requirement. Lack of a SWISS-PROT match may indicate differential representation of alternate splice products, differences in the gene type designation (protein-coding vs. non-coding), known gaps in CCDS for genes with limited sequence data, and differences that can be correlated to the reference genome sequence including small sequence differences (mismatches, insertions, or deletions), assembly gaps, copy number variation, or alternate haplotypes. Since SWISS-PROT is centered on proteins, it includes records for which a direct correlation to a CCDS cannot be expected because the categories are not in scope for CCDS. Among those are entries for human endogenous retrovirus (HERV) proteins, mature immunoglobulin proteins resulting from genomic rearrangement events, small physiologically active peptides that may result from enzymatic reactions, and putative uncharacterized proteins that may be alternatively interpreted by another group as a pseudogene or non-protein-coding RNA.
The third assessment uses the reading frame conservation (RFC) methodology (Kellis et al. 2003) to compare the proteincoding evolutionary signature of genes in CCDS with those from the RefSeq and Ensembl collections that do not contain CCDS proteins (see Supplemental Table 2 ). The RFC score is the percentage of nucleotides whose reading frame is evolutionarily conserved across species. Previous work has shown that 98% of the well-studied human genes have RFC scores >90 (Clamp et al. 2007) . Figure 3 shows the distribution of the RFC scores of the CCDS, RefSeq, and Ensembl loci for human and mouse, along with a control set of non-protein-coding DNA for human. In the human set, 95.9% of the CCDS genes have an RFC score above 90. Figure 1 . The percentage of mouse CCDS proteins that are found in any HomoloGene cluster versus those in a cluster that also contains a human CCDS protein (first two bars, respectively). For the latter category, results are further categorized based on protein length differences for the human and mouse homologous proteins.
In contrast, 37.6% and 44.3% of the non-CCDS RefSeq and Ensembl loci, respectively, have scores above RFC 90, and only 1.2% of the control set has RFC scores >90. In mouse, 93.5% of the CCDS genes exceed the RFC 90 threshold, compared to 36.8% of the RefSeq non-CCDS genes and 46.3% of the Ensembl non-CCDS genes scoring above RFC 90. In both human and mouse, the CCDS gene set shows significantly stronger evidence of evolving in a manner consistent with protein-coding genes than the RefSeq and Ensembl loci that do not contain CCDS proteins. The weakscoring genes tend to be the genes that require careful review by annotators. For instance, 35% of human RefSeq genes with low RFC scores (<90) are single-exon genes, while 6% of those with a high RFC score ($90) are single-exon genes. Genes with low RFC scores are also enriched for segmental duplications with 31% of low RFC RefSeq genes overlapping regions of segmental duplication (Bailey et al. 2001) , compared to only 9% of the high RFC scoring genes being in segmental duplications. Similarly, 41% of the low RFC human RefSeqs are identified as originating by retrotransposition , while only 18% of high RFC ones are categorized as retro-copies.
Access to CCDS data
NCBI hosts a public website for the CCDS project (http://www.ncbi.nlm.nih.gov/ CCDS/) that includes information about the collaboration, provides links to reports and FTP download, and provides a query interface to retrieve information about CCDS sequences and locations. The interface supports query by multiple identifiers including official gene symbols, CCDS ID, Entrez Gene ID ), or sequence ID (RefSeq, Ensembl ID, or Vega ID). Query results are presented in a table format with links provided to access the full report details for each CCDS ID (see Supplemental Fig. 1 ). Multiple CCDS IDs are reported for a gene if both data sets consistently annotated more than one CDS location. The CCDS ID-specific report page, shown in Figure 4 , provides a detailed report for the CCDS ID. Some records also include a Public Note, provided by a curator, summarizing the rationale for an update, withdrawal, or to explain representation choices. Reports may include an update history for associated sequence records when relevant (Supplemental Fig. 2 ).
All collaborating groups indicate the CCDS ID on gene and/or protein report pages, and Genome Browsers indicate when a CCDS is available for a locus using either display style (coloration), text labels, or by providing as a data track (Supplemental Fig. 3 ). For those interested in downloading the full CCDS . These graphs compare the RFC scores for CCDS loci with those of RefSeq and Ensembl loci that do not contain a CCDS protein, as well as a control data set for human. Since the controls were designed to have a similar alignment coverage to well-known genes, loci in other gene sets with less alignment coverage will score less than the controls. data set, the collaboration provides reports of the associated identifiers as well as the sequence data for anonymous FTP (ftp:// ftp.ncbi.nih.gov/pub/CCDS/). Please refer to provided README files for descriptions of information provided and file formats.
Manual curation of the CCDS data set
Coordinated manual curation, a critical aspect of the CCDS project, is supported by a restricted-access website and a discussion e-mail list. The collaboration has generated standardized curation guidelines for selection of the initiation codon and interpretation of upstream ORFs and transcripts that are predicted to be candidates for nonsense-mediated decay (NMD) (Lejeune and Maquat 2005) . Curation occurs continuously, and any of the collaborating centers can flag a CCDS ID as a potential update or withdrawal. Planned updates that are either under discussion or have achieved consensus agreement are indicated in the public CCDS website by a change in the status of the CCDS ID (Supplemental Table 1 ). Conflicting opinions are addressed by consulting with scientific experts or other annotation curation groups such as the HUGO Gene Nomenclature Committee (HGNC) (Bruford et al. 2008) and Mouse Genome Informatics (MGI) (Eppig et al. 2005) . If a conflict cannot be resolved, then collaborators agree to withdraw the CCDS ID until more information becomes available.
To date, we have reviewed more than 14,000 CCDS proteins and confirmed the existing CDS annotation with no change. Review also resulted in the removal of 530 CCDS IDs and suggested updates to 1014 proteins. If a CCDS protein is updated, the CCDS ID version number is incremented, and often a note is provided explaining the update. For example, review of the protein annotation (CCDS ID 10689) for the human SRCAP gene resulted in an N-terminal extension that adds an HSA domain that is found in DNA-binding proteins and is often associated with helicases. The HSA domain is consistent with the other domains found in the protein and with the presumed function of this protein as a component of the SRCAP chromatin remodeling complex ( Johnston et al. 1999; Wong et al. 2007 ). This significant improvement to the protein annotation was immediately available in the RefSeq transcript and protein sequences and in the Vega and UCSC Genome Browsers. This improvement became available in the NCBI and Ensembl Genome Browsers following a recalculation of the annotation for the human genome. Note there is no corresponding CCDS ID for the mouse Srcap locus yet, primarily owing to insufficient transcript data but confounded by the observation of differences in the exon definition compared to the human coding sequence.
Discussion
Although the human and mouse genome sequences have been of ''finished'' quality for several years, refinements to the annotation of protein-coding genes continue to take place. Until the Figure 4 . Detailed CCDS ID report page for a MXI1 protein. The CCDS report page presents three tables of information followed by nucleotide and protein sequences for the annotated CDS. The first table summarizes the status for the specified CCDS ID. Colored icons provide links to related resources, to a history report (orange H icon), or to re-query the CCDS database with a different type of identifier. (Red G icon re-queries the CCDS database by GeneID to return all CCDS IDs available for a gene.) A Public Note is provided for a subset of curated records to explain the nature of, and/or the reason for, an update or withdrawal. The sequence identifiers table reports sequences tracked as members of the CCDS ID. A checkmark in the first column (Original) identifies sequence identifiers represented on the annotated genome and included in the analyzed input data sets, and a checkmark in the second column (Current) identifies those that are considered current members (see Supplemental Fig. 2) The Chromosome Locations table reports the genomic coordinates of each exon of the CDS with links to view the annotation in different browsers-the violet icons (N) NCBI; (U) UCSC; (E) Ensembl; and (V) Vega. The nucleotide sequence of the CDS, derived from the genome sequence using the reported exon.
inception of the CCDS project, it was difficult to identify which protein annotations were represented consistently by the major browsers. The CCDS project solves this problem and establishes a framework to support well-supported, consistent, comprehensive annotation of the protein-coding content of the human and mouse genomes. The CCDS project has already identified 37,866 consistently annotated human and mouse CDSs for 33,945 genes and assigned them stable, versioned identifiers. By developing annotation standards, coordinating review of automated annotation, and documenting annotation decisions, the CCDS group continues to make a major contribution to the usability of the human and mouse genomic sequences.
The three independent methods used to assess the CCDS collection demonstrate that the genes included are highly likely to be protein-coding loci. Comparison to HomoloGene data indicates that at least 77% of the mouse genes with an associated CCDS ID have a homologous gene in human with an associated CCDS ID. Of these, the majority of the homologous CCDS proteins have a comparable length. Review of identified homologs with larger length differences indicates that the majority of them reflect valid differences due to alternate splicing. Comparison to another highly curated data set, SWISS-PROT, showed that 81% of the SWISS-PROT proteins are identical or highly similar to those encoded by CCDS, with similar results for mouse and human. The RFC analysis results indicate that 95% of the CCDS proteins do have an evolutionary signature that is consistent with their protein-coding designation.
The absence of a CCDS ID for a putative protein-coding gene annotation does not necessarily indicate that annotation is of poor quality; it indicates only that annotation is not yet consistent and requires additional review. Causes of annotation differences include resource-specific automatic annotation methods, timing of manual curation updates, conflicts between genomic and cDNA evidence, and incomplete curation guidelines on evaluating whether or not a locus is protein-coding, how much evidence is required to provide annotation, or where splice junctions should be annotated in repetitive regions. Until we have robust data from proteomic analyses, it is indeed a challenge to identify genes that are protein-coding, whether or not they are in the CCDS set. Supplemental Table 3 summarizes one approach to this problem, namely, classifying officially named genes thought to be proteincoding that have not yet been assigned a CCDS ID. Some have been assigned a RefSeq protein accession, many of which became available since the last CCDS analysis and are expected to gain a CCDS ID in the next analysis; some are associated with genome assembly issues that prevent representing the preferred protein from the genomic sequence; some are associated with protein sequence but are not in the RefSeq NM/NP set (often because the protein data appear to be partial); and some loci, perhaps historical, have no associated protein sequence at all. It is important to note that a CCDS ID represents consistency between annotation resources-it does not indicate that the annotation has been manually reviewed. We welcome feedback from the scientific community either regarding current annotations or to provide data and help with annotating new loci (see the CCDS website for contact information).
The benefits of the CCDS project extend beyond the CCDS data set currently available for the human and mouse genomes. The collaboration supporting the CCDS analysis process has resulted in improvements in automated annotation methods, quality assessment, and manual curation that are applied to many genomes. Discussions about evidence for annotation and publications between the RefSeq, Havana, and UCSC curation staff have resulted in re-evaluation of genomic sequence including assembly issues, correction of annotation errors, and identification of loci for which additional experimental validation is needed. Questions about the genomic sequence are reported to the Genome Reference Consortium (http://www.ncbi.nlm.nih. gov/genome/assembly/grc/index.shtml); annotation errors are resolved collaboratively ensuring consistent representation at all sites, and loci in need of experimental validation are reported to the GENCODE project. Experimental validation of transcripts and splice sites will occur as part of the GENCODE scale-up project (http://www.sanger.ac.uk/encode/), which builds on the successful GENCODE pilot project (Harrow et al. 2006) . GENCODE is part of the extended human Encyclopedia of DNA Elements (ENCODE) project (The ENCODE Project Consortium 2007). Annotated transcripts highlighted for validation will be confirmed in an array of tissues using RT-PCR or RNAseq. The resulting sequence will be fed back into the CCDS project as supporting evidence.
The CCDS group is thus a key participant in improving the representation of the human and mouse genomes. For example, we are collaborating with the HGNC to match loci they have named to the human genomic sequence. Curation is also focused on human-mouse homologous proteins for which one lacks a CCDS ID, and protein-coding loci with associated SWISS-PROT proteins for which there is no corresponding CCDS ID. An additional long-term goal is to add attributes that indicate where transcript annotation is also identical (including the UTRs) and to indicate splice variants with different UTRs that have the same CCDS ID. It is also anticipated that as more complete and highquality genome sequence data become available for other organisms, annotations from these organisms may be in scope for CCDS representation.
Methods

Identifying the candidate CCDS groups and tracking updates
Following the release of a re-annotation of the human or mouse reference genomes by both NCBI and Ensembl, we compared the genome annotation data sets provided by NCBI and Ensembl (Supplemental Fig. 4 ) to identify protein-coding annotations that are identical (start codon, stop codon, splice junctions) and do not include in-frame stop codons or apparent frameshifts. The fulllength translation of proteins that include the amino acid selenocysteine (identified as the codon UGA) is provided when collaborators are consistent in annotating an internal stop codon. Identical annotations are subject to quality assessment tests and assessed to identify whether they correspond to existing CCDS IDs or are novel. Existing CCDS IDs are tracked using the combination of sequence identifiers and chromosomal coordinates. The version number is incremented if the annotated exon coordinates and predicted protein product have changes, in which case it is required that they have been identically updated in both annotation sources owing to coordinated curation (see below and Supplemental Table 1 ). Novel entries are assigned a unique CCDS ID with an initial version of 1. Although mechanisms are in place in the Ensembl and NCBI annotation pipelines to ensure that existing CCDS entries are stably incorporated in the whole genome reannotation process, it is possible that final annotation of a CCDS protein may not be included or may no longer match, and so the CCDS entry is determined to be ''lost'' by the comparative process described above, in which case, they are flagged for manual follow-up.
The primary data represented by a CCDS ID are the chromosome coordinates of the annotated protein-coding exons and the nucleotide and conceptually translated protein sequence obtained from those coordinates. Ancillary data associated with the CCDS ID include sequence IDs and gene IDs included in the NCBI and Ensembl data sets. Each CCDS ID includes at least one protein identifier from both NCBI and Ensembl; a CCDS ID can include additional protein identifiers from either data set when they are predicted from transcripts that differ only because of alternate splicing in the untranslated region (i.e., when the proteincoding annotation is identical).
Quality assessment for a CCDS build
We have implemented a series of tests that assess the protein sequence, conservation, and likelihood that annotation erroneously represents a pseudogene as protein-coding. The Ensembl and NCBI protein length and sequence are compared by alignment to identify and discard proteins that are discordant owing to annotation or processing error or insertion/deletion differences between NCBI RefSeq proteins and the protein annotated on the reference genome. Two types of protein comparisons are done: (1) protein sequences provided by each annotation source as FASTA files are compared to the conceptually translated CDS sequence that is extracted de novo from the genome annotation coordinates, and (2) proteins provided as FASTA by each annotation data source are compared to each other. Putative retrotransposed pseudogenes are identified from mRNAs [with poly(A) tails removed] that align to the genome using BLASTZ (Schwartz et al. 2003 ) at more than one location. Alignments are scored for a series of features to identify putative retrotransposed pseudogenes as previously described ). Protein models are also evaluated for genome conservation patterns that may indicate that the gene is not functional in human. Analysis of BLASTZ cross-species alignments to the human genome gene annotation detects potential problems including: nonconserved start and stop codons, nonconserved splice sites, uncompensated insertionor deletion-associated frameshifts, and in-frame stop codons. Cross-species alignments included chimpanzee, mouse, rat, dog, chicken, and rhesus; only syntenic alignments are used from the assembled genomes. Additional QA tests are applied by NCBI to the RefSeq sequences included in the CCDS database as previously described ).
Exchange of curation data
NCBI maintains a relational database that tracks CCDS candidates; locations and identifiers; results of quality assurance tests, curator comments; and CCDS IDs and versions. A database extraction is distributed via a private ftp site to the members of the CCDS collaboration on a daily basis. A restricted-access website supports the collaboration, and a public access website and ftp site disseminate data for CCDS IDs.
Quality assessment of the current human and mouse CCDS data set
HomoloGene
The number of mouse and human CCDSs with homologs in other species was calculated by determining whether the current CCDS genes for human and mouse are members of a HomoloGene group (release 62) that has a gene from at least one other species as a member. Additional filtering identified HomoloGene clusters containing human and mouse genes where the corresponding human and mouse loci are both associated with a CCDS ID.
Comparison to SWISS-PROT
Manually curated SWISS-PROT records (Apweiler et al. 2008 ) (release 55.5) were obtained via the EBI ftp site (ftp://ftp.ebi.ac.uk/ pub/databases/uniprot/). A SWISS-PROT accession number may represent more than one sequence isoform. For example, Q8NCE2 includes annotation indicating that amino acids 479 through 538 are missing in isoform 3. Therefore, the SWISS-PROT data set was processed with VARSPLIC (Kersey et al. 2000) to derive an expanded data set (isoforms) by extracting alternate splice products based on record annotation. Exonerate (Slater and Birney 2005) was used with the affine:local model and a sequence identity threshold of 95% to align UniProt sequences to CCDS proteins. Alignments were analyzed and binned into several different categories, with interpretations based on an evaluation of alignments to the expanded set of alternate protein variants versus alignments to the UniProt record where the record is defined as a CCDS protein alignment with the highest coverage score to any of the set of splice variants extracted from the UniProt record. Results were binned as follows: (1) alignment found or not, (2) overall sequence identity, (3) N terminus identical or not, (4) C terminus identical or not, and (5) the alignment coverage of the UniProt protein.
RFC conservation analysis
Conservation analysis was performed using genomic annotations of transcripts for human assembly NCBI 36 (UCSC hg18) and mouse assembly NCBI 37 (UCSC mm9) for CCDS along with the corresponding RefSeq and Ensembl protein-coding gene sets (Supplemental Table 2 ). Human transcripts were scored against mouse and dog, with mouse transcripts scored using human and dog. The score for a gene is the maximum RFC for any of its transcripts against either of the aligned genomes. A control data set of randomized human sequences was also scored, as previously described (Clamp et al. 2007 ). Controls are non-protein-coding regions of the genome that serve as a null model, with similar structure, GC content, alignment coverage, and mutation rates as for well-known protein-coding genes.
